Table 1 (abstract P294). Subtypes of pulmonary involvement at diagnosis and during follow-up
From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Pulmonary manifestations collected by the UK JSLE Cohort Study | Diagnosis (n=109/480) | 10-14 m (n=30/157 ) | 22-26 m (n=22/128) | 58-62 m (n=11/49) |
|---|---|---|---|---|
Serositis (ACR classification criteria defined) | 44 (41%) | 22 (73%) | 18 (82%) | 9 (82%) |
Pleuropericardial pain | 29 (27%) | 2 (7%) | 3 (14%) | 1 (9%) |
Dyspnea | 38 (35%) | 2 (7%) | - | 2 (18%) |
Effusion (pericardial / pleural) | 35 (32%) | - | - | - |
Mild or intermittent chest pain | 29 (27%) | - | - | - |
Pulmonary function fall by >20% | 7 (7%) | 2 (7%) | - | - |
Pulmonary hemorrhage/vasculitis | 1 (1%) | 1 (4%) | - | - |
Interstitial alveolitis/pneumonitis | 5 (5%) | - | - | - |
Pleural fibrosis | 1 (1%) | 1 (4%) | 1 (5%) | - |